Published by Josh White on 29th July 2022
(Sharecast News) - Women's health-focussed biopharmaceutical company Ovoca Bio announced the successful completion of participant enrollment in a phase 2 dose-ranging study assessing 'orenetide' on Friday.
URL: http://www.digitallook.com/dl/news/story/32857418/...